Stock screener

GSK

Conviction 27HealthcareScan · Mon, Jul 20, 2026
GSK$50.05-3.31%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 3.73M
Apr 20May 6May 26Jun 11Jul 1Jul 20
WSB mentions · 24h changelatest +200.00%· 3 mentions
Apr 20May 6May 26Jun 11Jul 1Jul 20
GSK plcDrug Manufacturers - Generalwww.gsk.com ↗
Price50.05
Change-3.31%
Gap-0.73%
Rel volume0.66×
Avg volume3.73M
Avg $ vol194.38M
SMA 2052.11
SMA 5051.45
SMA 20051.24
Price vs 50-2.73%
Price vs 200-2.33%
MA stackmixed
50/200 cross—
Supertrenddown · 53.91
RSI (14)41
MACD hist-0.21
MACD crossbear · 4d
Stoch %K / %D1 / 25
ADX (14)10
+DI / −DI20 / 26
RSI divergenceBearish
MACD divergenceBearish
ATR %+2.40%
ADR %1.95%
52w high61.18
52w low36.20
From 52w high-18.20%
Above 52w low+38.25%
New 52w highNo
SqueezeFired
Bollinger width6.86%
%B-0.08
Donchian pos0.82%
Donchian high54.29
Donchian low50.01
AVWAP (52w high)53.87
vs AVWAP high-7.11%
AVWAP (52w low)48.95
vs AVWAP low+2.24%
OBV trendFlat
Chaikin MF (20)0.01
Today vs 20d0.66×
Avg vol (14d)3.73M
Avg vol (20d)3.73M
Avg $ vol (20d)194.38M
Market cap215.97B
RS 3m (vs SPY)-15.33%
RS 6m (vs SPY)-5.76%
RS line new highNo
Trend template4/8
Technical rank39.6
1 week-4.29%
1 month-4.04%
3 months-14.23%
6 months+1.88%
1 year+37.22%
YTD+0.84%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target68.55
Target upside36.98%
Analyst ratingBuy
Institutional18.63%
Ent. value215.97B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - General
ExchangeNYSE
Shares out2.03B
Employees66.84K
ListedWed, Aug 18, 1976
Free float1.95B
Float %97.2%
Short interest12.76M
Days to cover3.3d
Short volume45.3%
Squeeze score21 / 100
Next earningsTue, Jul 28, 2026 · pre-mkt (8d)
EPS forecast$1.27 · 4 est
Last EPS vs est$1.24 vs $1.17
Last surprise+6.0% beat
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank39.6 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance53.87
Support49.46
Days since event—
Candle confirm—
News sentiment—

Congress activity

Disclosed STOCK Act trades in GSK · 10 recent

All disclosures →
MemberSideAmount
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-31
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-30
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-09-23
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-11-18
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-08-04
Buy$1K–$15K
Robert B. Aderholt
Robert B. Aderholt
house · R · AL · traded 2025-07-28
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-24
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Buy$1K–$15K
Bruce Westerman
Bruce Westerman
house · R · AR · traded 2025-04-21
Sell$1K–$15K
Bruce Westerman
Bruce Westerman
house · R · AR · traded 2025-03-03
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in GSK

No recent insider (Form 4) filings in GSK. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GSK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.